Milton H. Werner - 17 Nov 2021 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Milton H. Werner
Issuer symbol
IKT
Transactions as of
17 Nov 2021
Net transactions value
+$46,558
Form type
4
Filing time
19 Nov 2021, 07:13:32 UTC
Previous filing
19 Aug 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKT Common Stock Purchase $34,787 +17,569 +292% $1.98 23,589 17 Nov 2021 Domestic Partner F1
transaction IKT Common Stock Purchase $2,167 +1,100 +4.9% $1.97 23,589 17 Nov 2021 Domestic Partner F1
transaction IKT Common Stock Purchase $6,245 +3,186 +16% $1.96 23,589 17 Nov 2021 Domestic Partner F1
transaction IKT Common Stock Purchase $2,588 +1,334 +6% $1.94 23,589 17 Nov 2021 Domestic Partner F1
transaction IKT Common Stock Purchase $772 +400 +1.7% $1.93 23,589 17 Nov 2021 Domestic Partner F1
holding IKT Common Stock 5,293,580 17 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.